PROVIDER PROFILE · NPI 1376779124

Daniel Chen

Internal MedicinePhiladelphia, PAI

MEDICARE UTILIZATION · PART B · 2024

No data available for this provider in 2024.

PRESCRIBING · PART D · 2024

Total Rx claims

2,281

Beneficiaries

—

Total drug cost

$312K

Distinct drugs

Brand share

28.8%

Top prescribed drugs

Atorvastatin Calcium171 claims

Empagliflozin102 claims

Gabapentin88 claims

Fluticasone Propionate87 claims

Diclofenac Sodium83 claims

QUALITY · MIPS · 2024

No data available for this provider in 2024.

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

No data available for this provider in 2024.

REFERRAL NETWORK

Where Daniel Chen's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 3 inbound referrers · 3 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
Laboratory Corporation Of America Holdings Clinical Laboratory · Raritan, NJ	31	100
ESPERANZA HEALTH CENTER INC	29	78
ESPERANZA HEALTH CENTER, INC.	13	26

Refers patients to

Outbound — where patients go next

Physician	Patients	Visits
ESPERANZA HEALTH CENTER INC	77	252
Laboratory Corporation Of America Holdings Clinical Laboratory · Raritan, NJ	28	68
TEMPLE UNIVERSITY HOSPITAL, INC	22	66

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history